Online GLP-1 Sellers Often Bypass Meaningful Clinician Oversight
Direct-to-consumer telehealth platforms have changed how people access glucagon-like peptide-1 receptor agonists for managing obesity. A recent secret shopper…
-
-
GLP-1 Therapy and Antihypertensive Regimens: Assessing the Risk of Hypotension and Syncope
Clinicians are seeing more patients who mix glucagon-like peptide-1 receptor agonist therapy with multiple blood pressure medications. This combination…
-
Semaglutide and Metabolism: What You Should Know
Semaglutide is a widely prescribed medication for obesity and type 2 diabetes. The drug is the active ingredient in…
-
GLP-1 Receptor Agonists and Urinary Incontinence in Women With Obesity and Type 2 Diabetes
Urinary incontinence affects a significant number of women who are obese and have type 2 diabetes. Extra body fat…
-
Skin Care On GLP-1: How To Protect And Firm Skin During And After Rapid Weight Loss
Glucagon-like peptide-1 receptor agonists have significantly changed how we manage obesity and type 2 diabetes. Medications like Ozempic, Wegovy,…
-
Pre-Pregnancy GLP-1 Therapy and Gestational Diabetes: Why Discontinuation Timing Matters
Glucagon-like peptide-1 receptor agonists and tirzepatide have changed how we manage obesity and type 2 diabetes. As a result,…
-
GLP-3 Versus GLP-1: A Clinical Comparison for Weight Loss Management
Clinicians and patients often come across the term GLP-3 when discussing new obesity treatments. This term does not have…
-
8 Common GLP-1 Sexual Side Effects Explained
GLP-1 receptor agonists have changed weight management and blood sugar control for millions of patients. Most clinical focus tends…
-
How to Exercise on GLP-1 Medications: A Clinical Guide
Glucagon-like peptide-1 receptor agonists have changed the way we treat obesity and type 2 diabetes. Medications like semaglutide and…
-
Do GLP-1 Receptor Agonists Alter Personality and Emotional Function?
Demand for weight loss medications is at an all-time high. National survey data show that about half of adults…
